iJOBS Site Visit: Bristol Myers Squibb
iJOBS Blog
by Soumyadipa Das
by Soumyadipa Das
Written by: Soumyadipa Das
If you have a background in science and currently looking to work for big pharmaceuticals, then you have opened the perfect article.
Written by: Soumyadipa Das
by Helena Mello Founded in 1807, Wiley Publishing (then John Wiley and Sons) is a worldwide company with over 1600 journals published. On October 28, 2019, the Rutgers iJOBS program visited Wiley’s New Jersey site to hear from a variety of employees on the publishing industry and where the company stands within it. There are two main areas within Wiley: research and Education (Wiley Education houses the For Dummies series!).
by Helena Mello If you are a recurrent reader of this blog you probably have heard of Medical Communications (Med Comm). We cover this topic frequently not just because we think Med Comm can be a great career for those with a science background, but also because it is a rapidly growing field in the healthcare industry. With that in mind, the Rutgers iJOBS program organized a site visit to Med Comm giant McCann Health.
I didn’t know what I expected on Thursday when I traveled to Bridgewater, NJ to visit GlaxoSmithKline’s (GSK) Medical Affairs office. This was my first opportunity to get a day-in-the-life industry perspective during my time in graduate school. If you read any of our previous blog posts or even just the description of the iJOBS program, you will understand that its sole purpose is to expose graduate students and post-docs to non-academic career options.
On November 1, 2017, iJOBS hosted a site-visit to Bayer in Whippany, NJ. This location is Bayer’s U.S. headquarters for the Pharmaceuticals and Consumer Care divisions. The day began with a talk by Edio Zampaglione, MD, Vice President of U.S. Medical Affairs for Women’s Healthcare and Neurology.
On November 29, the New Brunswick site of Bristol-Myers Squibb (BMS) hosted students from Rutgers University, Johns Hopkins University, and the University of Maryland. BMS is a global bio-pharmaceutical company whose drug portfolio includes oncology, immunoscience, cardiovascular, genetic diseases, and fibrotic diseases.
by: Dharm Patel